- Conditions
- CLL, Chronic Disease, Disease Attributes, +18 more
- Locations
-
- Highlands Oncology Group ( Site 5405) Springdale, Arkansas, United States
- MemorialCare Health System - Long Beach Medical Center ( Site 5421) Long Beach, California, United States
- Memorial Hospital West ( Site 5410) Pembroke Pines, Florida, United States
- Oregon Health and Science University ( Site 5425) Portland, Oregon, United States
Clinical trial condition
Leukemia, Lymphocytic, Chronic, B-Cell
Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.
45 public trials
6 recruiting studies
Leukemia, Lymphocytic, Chronic, B-Cell trial results
NCT06364423
- Conditions
- Acute Lymphoblastic Leukemia, B-Lymphocytic Leukemia, Chronic, B-cell Chronic Lymphocytic Leukemia, +20 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07602088
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Spitalul Universitar de Urgenta Bucuresti Bucharest, Romania
NCT06299540
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Institut Universitaire du Cancer Toulouse Oncopole Toulouse, France
NCT00626496
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT02869529
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France
Enrolling by invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +30 more
- Locations
-
- Linear Clinical Research Ltd Nedlands, Australia
- Scientia Clinical Research Randwick, Australia
- Ghent University Hospital Ghent, Belgium
- Hopital Claude Huriez Lille, France
Active, not recruiting
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
NCT05963074
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- The Oncology Institute Clinical Research Cerritos, California, United States
- Cancer and Blood Specialty Clinic Los Alamitos, California, United States
- SLO Oncology and Hematology Health Center San Luis Obispo, California, United States
- Providence Medical Foundation Santa Rosa, California, United States
Active, not recruiting
A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
NCT05424822
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- City of Hope Duarte, California, United States
- Icahn School of Medicine at Mount Sinai New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
Active, not recruiting
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
NCT03331198
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- Local Institution - 0006 Birmingham, Alabama, United States
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Local Institution - 0043 Gilbert, Arizona, United States